You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
Non-interventional study to assess reaching of cholesterol target values in patients treated with HMG-CoA reductase inhibitors in Bosnia and Herzegovina
- Disease
- dyslipidaemia, hypercholesterolaemia
- Drug Name
- Crestor
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Non-Interventional Study
- Start Date
- Jan 4, 2012
- Study Name
- NIS-CBA-CRE-2011/1
- ClinicalTrials.gov ID
- NCT01483950
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
